PulseAugur
EN
LIVE 10:22:21
中文(ZH) 天风证券:创新药产业链景气度提升,关注大单品放量及相应机会

Innovative drug sector sees growth potential amid tech stock sell-off · 1 source tracked

A recent report from Tianfeng Securities indicates a positive outlook for the innovative drug industry, driven by ongoing business development deals and sustained R&D investment. The report suggests that this trend will lead to high growth rates across the entire innovative drug industry chain. Concurrently, a separate report from Goldman Sachs highlights a record exodus of hedge funds from US tech stocks over the past two months, with significant sell-offs observed in semiconductor, storage, and AI infrastructure sectors. AI

IMPACT The tech stock sell-off, particularly in AI infrastructure, may impact investment and development in the AI sector.

RANK_REASON The item discusses financial analysis and market trends from multiple sources, rather than a primary event.

Read on 36氪 (36Kr) →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

Innovative drug sector sees growth potential amid tech stock sell-off · 1 source tracked

COVERAGE [1]

  1. 36氪 (36Kr) TIER_1 中文(ZH) ·

    Tianfeng Securities: The prosperity of the innovative drug industry chain is improving, focusing on the release of blockbuster drugs and corresponding opportunities

    36氪获悉,天风证券研报认为,在国内BD交易热潮的持续下,创新药研发热潮有望持续。天风证券认为在创新药研发需求持续火热的情况下,国内需求有望持续高增长,有望带动创新药产业链整体板块业绩高增速。关注大单品放量及相应机会。